Best printers for Home

Best Mixer Grinder

Best wired Earphones

Best 43 Inch TV in India

Best Wi Fi Routers

Best Home Theatre in India

Smart Watch under 5000

Best Laptops for Education

Best Laptop for Students

A couple of years back, anybody with a full-time job across the globe used to say that they work a "9 to 5 (9 am to 5 pm)." However, as per a recent report, that is no longer the average working hours and more and more employees are now adapting to a <keyword id="23061305" type="General" weightage="20" keywordseo="flexible-work-style" source="keywords">flexible work style</keyword>. The <keyword id="20534318" type="General" weightage="20" keywordseo="coronavirus-pandemic" source="keywords">coronavirus pandemic</keyword>, in 2020, saw a major change in work patterns across the globe. As companies shifted their operations remote overnight, employees began working at their own pace, at their own time. At the time, many reports had come up that the future of work would be flexibility in terms of working hours and location. And as per a latest report, that has started happening. <h2>Bye bye 9-to-5 </h2> The standard 9-to-5 workday has now transitioned to more of a 10-to-4 routine, according to a 2023 Global Traffic Scorecard by INRIX Inc, a traffic analysis firm. This shift means fewer people are commuting during the early hours, creating a new trend in daily traffic flow. With fewer people hitting the road in the early morning or evening, traffic congestion has now shifted to the middle of the day. A CNBC report quotes Bob Pishue, a transportation analyst who authored the INRIX report, saying, "We’re seeing less activity in the morning and evening but much more around noon." Surprisingly, the number of trips made around noon is now almost equal to those at 9 am and 5 pm What was once a lull between morning and evening traffic has transformed into a peak period of congestion. <h2><keyword id="19901232" type="General" weightage="100" keywordseo="work-life-balance" source="keywords">Work-life balance</keyword> takes center stage </h2> The report also quotes David Satterwhite, CEO of Chronus. He says that many employees have embraced the ability to work remotely and only come into the office when absolutely necessary. This might mean arriving late, leaving early, or coming in for a brief meeting before heading back home. This trend, often called “coffee badging,” has become widely accepted as employees pop into the office for short stints and then continue their workday elsewhere. A recent survey from Owl Labs found that 58 percent of hybrid workers admitted to checking into the office for just a few hours before leaving. These days, more workers prioritise work-life balance, flexible hours, and mental health support over climbing the corporate ladder. Many are reluctant to spend more time at the office than necessary. In fact, if the option to work from home were removed, 66% of workers said they would start searching for a new job that offered more flexibility, according to Owl Labs. Of those, around 39% would quit right away. In January this year, a study conducted by Randstad also revealed that workers prioritise work-life balance over salary when evaluating potential job opportunities. According to the study, 57 percent of employees would reject a job offer if it negatively impacted their work-life balance. SEE ALSO: <a href="https://www.businessinsider.in/tech/news/openai-to-meta-ai-companies-that-were-accused-of-copyright-infringement/articleshow/113088658.cms" data-type="tilCustomLink" target="_blank"></a><a href="https://www.businessinsider.in/business/news/nykaa-sues-tata-cliq-ceo-gopal-asthana-for-contract-breach-says-he-approached-employees-to-join-rival-company/articleshow/113082094.cms" data-type="tilCustomLink" target="_blank">Nykaa sues Tata Cliq CEO Gopal Asthana for contract breach, says he approached employees to join rival company</a> OpenAI to Meta: AI companies that were accused of copyright infringement

No more 9 to 5: Employees are coming to work late and leaving early, new data shows

The Indian Council of Medical Research Director General Dr Rajiv Bahl on Monday criticised a recently published study on the long-term safety analysis of the <keyword id="9485939" type="General" weightage="100" keywordseo="covaxin" source="Orion">Covaxin</keyword> in adults and adolescents for its poor methodology and design, and clarified the article misleadingly and erroneously "acknowledges" <keyword id="19918794" type="General" weightage="20" keywordseo="ICMR" source="keywords">ICMR</keyword>. Dr Bahl said the study had no control arm of unvaccinated individuals for comparing the rates of events between the vaccinated and unvaccinated groups. Hence, the reported events in the study cannot be linked or attributed to COVID-19 vaccination. He added that the ICMR is not associated with the study and has not provided any financial or technical support for the research. The ICMR DG has written a letter to the authors of the paper and Editor of the journal to immediately remove the acknowledgement to ICMR and publish an erratum. A research paper, titled 'Long-Term Safety Analysis of the BBVl52 <keyword id="21730391" type="General" weightage="20" keywordseo="coronavirus-vaccine" source="keywords">Coronavirus Vaccine</keyword> in Adolescents and Adults: Findings from a l-Year Prospective Study in North India' stated that nearly one-third of the 926 participants in the study who received Bharat Biotech's anti-Covid vaccine Covaxin reported 'adverse events of special interest,' or AESI. Dr Bahl said that ICMR was acknowledged for research support without any prior approval of or intimation to ICMR, which is inappropriate and unacceptable. He stated that ICMR cannot be associated with this poorly designed study which purports to present a "safety analysis" of Covaxin due to several critical flaws. He said the study does not even provide background rates of observed events in the population, making it impossible to assess the change in incidence of observed events in the post-vaccination period. Baseline information of study participants is missing. The study tool used is inconsistent with 'Adverse Events of Special Interest (AESI)' as defined in the reference provided in the paper for AESI. The method of data collection has a high risk of bias, he said. Study participants were contacted telephonically one year after vaccination and their responses were recorded without any confirmation with clinical records or by physician examination, he pointed out. Dr Bahl also noted that similar acknowledgements to ICMR have been made in previous papers without permission, raising concerns about the authors' practices. "The authors have been urged to immediately rectify the acknowledgment to ICMR and publish an erratum. Additionally, they are asked to address the methodological concerns raised. Failure to do so may prompt ICMR to consider legal and administrative action," he said. The Editor has been asked to retract the paper which implicitly makes conclusions on <keyword id="21495684" type="General" weightage="20" keywordseo="vaccine-safety" source="keywords">vaccine safety</keyword> which are not supported by evidence. The study, conducted by researchers from the Banaras Hindu University from January 2022 to August 2023, stated that nearly 50 per cent of 926 study participants in the study complained of infections during the follow-up period, predominated by viral upper respiratory tract infections. Serious AESI, which included stroke and Guillain-Barre syndrome, were reported in one per cent of individuals, the study, which looked at long-term safety of the BBV152 (Covaxin) vaccine in adolescents and adults, claimed. The study involved 635 adolescents and 291 adults, who received the BBV152 vaccine.

BHU study on Covaxin side effects poorly designed, critically flawed: ICMR Director General

Not allowing yourself to be peer-pressured into downloading those tiresome dating apps may be the first best precaution you can take to protect your heart. Getting vaccinated for COVID-19 may well be the second, it turns out. A new international study examining the effects of vaccines on millions of patients in the UK, Spain and Estonia found that being vaccinated may be the trick to a healthier heart. In the first month after infection, the researchers found that the risk of <keyword id="25186" type="General" weightage="20" keywordseo="blood-clotting" source="Orion">blood clotting</keyword> plummeted by a whopping 78% in the limbic veins and 47% in the arteries of the vaccinated individuals. Avoiding these complications helped more than halve the <keyword id="32031" type="General" weightage="20" keywordseo="heart-failure" source="Orion">heart failure</keyword> risk among vaxxers compared to the non-vaccinated. <cmsannotation type="cmsannotation" annotationid="What does blood clotting have to do with COVID?" comment="subhead" text="What does blood clotting have to do with COVID?">What does blood clotting have to do with COVID?</cmsannotation> Unfortunately, just having blood inside your body isn’t enough to help you survive; the stuff needs to constantly move and slosh through your blood vessels, transporting and depositing oxygen and other nutrients around like silt on a river edge. However, certain conditions — such as diabetes and obesity — can cause some of your blood to abnormally coagulate, forming giant blockages that prevent your veins and arteries from moving blood around efficiently. This places an extra burden on your heart, which can lead it to fail. Research has shown that COVID-19 infections have the capability to cause unusual blood clots in multiple parts of the body, including the lungs and the legs. This can lead to organ failures, <keyword id="6357661" type="General" weightage="20" keywordseo="heart-attack" source="Orion">heart attack</keyword> and <keyword id="25191" type="General" weightage="20" keywordseo="stroke" source="Orion">stroke</keyword>. Fortunately, simply taking a wee bit of time off to get yourself jabbed by the <keyword id="24209" type="General" weightage="20" keywordseo="vaccine" source="Orion">vaccine</keyword> helps tremendously, it turns out. It wasn’t just heart failure and stroke; being vaccinated also reduced the risk of developing other heart-related diseases. This included scary conditions such as heart attacks and ventricular arrhythmia (an abnormal heartbeat), although this shield only persisted for the first 30 days after the infection. Despite not being at peak efficacy, the vaccine’s protection was potent enough to slash risk of heart failure by nearly 50% for up to a year after vaccination, the study found. This showed that even as the protective halo of the vaccine waned over time, it still continued to pack a punch. <cmsannotation type="cmsannotation" annotationid="Will this squash the vaccine side-effect debate?" comment="subhead" text="Will this squash the vaccine side-effect debate?">Will this squash the vaccine side-effect debate?</cmsannotation> There has been a second-wave of reluctance to take the COVID-19 vaccine, majorly due to concerns of long-term complications that can arise from them. The important thing to note is that while the vaccine can lead to heart issues in some people, it only takes place in extremely rare circumstances. Conversely, one study even showed that vaccination reduced the risk of long-COVID by a massive 67%. The researchers thus hope that these positive heart-related findings will help clear any vaccination hesitations among sceptics. However, more studies need to be conducted to conclusively understand the protection offered by booster doses in different populations. "Our findings probably reflect the fact that the vaccines are effective in reducing infection, and minimise the risk of severe COVID-19," explains study author Núria Mercadé-Besora. "These results could encourage COVID-19 vaccination among hesitant people who are worried about the potential risk of vaccine side effects." The findings of this study have been published in Heart and can be accessed <a href="https://heart.bmj.com/content/early/2024/01/24/heartjnl-2023-323483" data-type="tilCustomLink">here</a>.

COVID-19 vaccine can slash risk of post-infection heart failure by half, study finds

You Searched For "up coronavirus" and got 3 results

No more 9 to 5: Employees are coming to work late and leaving early, new data shows

Divyanshi Sharma

BHU study on Covaxin side effects poorly designed, critically flawed: ICMR Director General

PTI

COVID-19 vaccine can slash risk of post-infection heart failure by half, study finds

Ankush Banerjee

Popular Keywords

Buying Guides